Proliferative lesions found in rat kidneys after a single dose of cisplatin

Journal of the National Cancer Institute

Volumn 73, Issue 5, 1984, Pages 1235-1242

  Bulger, Ruth Ellen ^a   Dobyan, Dennis C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ANIMAL EXPERIMENT; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; KIDNEY; KIDNEY INJURY; LYSOSOME; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; CELL DIVISION; CISPLATIN; KIDNEY; MALE; MICROSCOPY, ELECTRON; RATS; RATS, INBRED F344; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0021691537     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/73.5.1235     Document Type: Article

References (46)

1. Gottlieb JA, Drewinko B. Review of the current clinical status of platinum coordination complexes in cancer chemotherapy. Cancer Chemother Rep 1975; 59:621-628.
2. Lippman AJ, Helson C, Helson L, Krakoff IH. Clinical trials of cis-diamminedichloroplatinum (NSC-19875). Cancer Chemother Rep 1973; 57:191-200.
3. Wittes RE, Cvitkivic E, Shah J, Gerold J, Strong EW. CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck. Cancer Treat Rep 1977; 61:359-366.
4. Choie DD, Longnecker DS, delCampo AA. Acute and chronic cisplatin nephropathy in rats. Lab Invest 1981; 44:397-402.
5. Chopra S, Kaufman JS, Jones TW, et al. Cis-diamminedichlorplatinum-induced acute renal failure in the rat. Kidney Int 1982; 21:54-64.
6. Safirstein R, Miller P, Dikman S, Lyman N, Shapiro C. Cisplatin nephrotoxicity in rats: Defect in papillary hypertonicity. Am J Physiol 1981; 241:F175-F185.
7. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity. II. Morphologic observations. J Pharmacol Exp Ther 1980; 213:551-556.
8. Ward JM, Fauvie KA. The nephrotoxic effects of cis-diamminedichloroplatinum (II) (NSC-119875) in male F344 rats. Toxicol Appl Pharmacol 1976; 38:535-547.
9. Dobyan DC, Hill D, Lewis T, Bulger RE. Cyst formation in rat kidney induced by cis-platinum administration. Lab Invest 1981; 45:260-268.
10. Griffith LD, Bulger RE, Trump BF. The ultrastructure of the functioning kidney. Lab Invest 1967; 16:220-246.
11. Gray JE. Chronic progressive nephrosis in the albino rat. CRC Crit Rev Toxicol 1977; 5:115-144.
12. Merski JA. Alterations of renal tissue structure during a 30-day gavage study with nitrilotriacetate. Food Chem Toxicol 1982; 20:433-440.
13. Alden CL, Kanerva RL. The pathogenesis of renal cortical tumours in rats fed 2% trisodium nitrilotriacetate monohydrate. Food Chem Toxicol 1982; 20:441-450.
14. Horning ES, Whittick JW. The histogenesis of stilboesterolinduced renal tumours in the male golden hamster. Br J Cancer 1954; 8:451-457.
15. Boyland E, Dukes CE, Grover PL, Mitchley BCV. The induction of renal tumours by feeding lead acetate to rats. Br J Cancer 1962; 16:283-288.
16. Vanepesch GJ, Vangenderen H, Vink HH. The induction of renal tumours by feeding of basic lead acetate to rats. Br J Cancer 1962; 16:289-297.
17. Haas GM, McDonald JH, Oyasu R, Battifora HA, Palouceh JT. Renal neoplasia induced by combinations of dietary lead subacetate and N-2-fluoroenylacetamide. In: Stanton K Jr, ed. Renal neoplasia. Boston: Little, Brown 8c Co., 1967:377.
18. Hard GC, Butler WH. Ultrastructural aspects of renal adenocarcinoma induced in the rat by dimethylnitrosamine. Cancer Res 1971; 31:366-372.
19. Hard GC, Butler WH. Morphogenesis of epithelial neoplasms induced in the rat kidney by dimethylnitrosamine. Cancer Res 1971; 31:1496-1505.
20. McGiven AR, Ireton JH. Renal epithelial dysplasia and neoplasia in rats given dimethylnitrosamine. J Pathol 1972; 108:187-190.
21. Riopelle JL, Jasmin G. Nature, classification, and nomenclature of kidney tumors induced in the rat by dimethylnitrosamine. J Natl Cancer Inst 1969; 42:643-662.
22. Dees JH, Reuber MD, Trump BF. Adenocarcinoma of the kidney. I. Ultrastructure of renal adenocarcinomas induced in rats by Af-(4′-fluoro-4-biphenylyl)acetamide. J Natl Cancer Inst 1976; 57:779-794.
23. Dees JH, Heatfield BM, Trump BF. Adenocarcinoma of the kidney. IV. Electron microscopic study of the development of renal adenocarcinomas induced in rats by N-(4′-fluoro-4- biphenylyl)acetamide. J Natl Cancer Inst 1980; 64:1547-1562.
24. Hinton DE, Heatfield BM, Lipsky MM, Trump BF. Animal model of human disease. Renal tubular carcinoma-animal model: Chemically induced renal tubular carcinoma in rats. Am J Path 1980; 100:317-320.
25. Hruban Z, Mochizuki Y, Morris HP, Slesers A. Ultrastructure of Morris renal tumors. J Natl Cancer InSt 1973; 50:1487-1495.
26. Morris HP, Wagner BP, Meranze DR. Transplantable adenocarcinomas of the rat kidney possessing different growth rates. Cancer Res 1970; 30:1362-1369.
27. Reuber MD. A model for carcinoma of the kidney in buffalo strain rats ingesting N-4(4′-fluorobiphenyl)acetamide. Gann 1974; 65:389-394.
28. Sempronj A, Morelli E. Carcinoma of the kidney in rats treated with beta-anthroquinoline. Am J Cancer 1939; 35:534.
29. Merkow LP, Epstein SM, Slifkin M, Pardo M. The ultrastructure of renal neoplasms induced by aflatoxin B[. Cancer Res 1973; 33:1608-1614.
30. Johannessen JV, Eker R, Sobrinho-Simones M. The ultrastructure of hereditary renal adenomas and adenocarcinomas in rats. J Submicrosc Cytol 1980; 12:463-473.
31. Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 1972; 14:407-417.
32. Miach PJ, Dawborn JK, Xipell J. Neoplasia in patients with chronic renal failure on long-term dialysis. Clin Nephrol 1976; 5:101-104.
33. Dunnill MS, Millard PR, Oliver D. Acquired cystic disease of the kidneys: A hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol 1977; 30:868-877.
34. Hughson MD, Hennigar GR, McManus JF. Atypical cysts, acquired renal cystic disease, and renal cell tumors in end stage dialysis kidneys. Lab Invest 1980; 42:475-480.
35. Ishikawa I, Saito Y, Onouchi Z, et al. Development of acquired cystic disease and adenocarcinoma of the kidney in glomer-ulonephritic chronic hemodialysis patients. Clin Nephrol 1980; 14:1-6.
36. Borland VG, Jackson CE. Effects of a fat-free diet on the structure of the kidney in rats. Arch Pathol 1931; 11:687-708.
37. Lalich JJ, Chun W, Park W, Pradhan B. Epithelial hyperplasia in the renal papilla of rats. Induction in animals fed excess sodium chloride. Archives Pathol 1974; 97:29-32.
38. Levine G, Sowinski R. Renal papillitis and urinary obstruction caused by a substituted pyrimidine. Toxicol Appl Pharmacol 1977; 42:603-606.
39. White J, Mori-Chavez P. Acute necrotizing renal papillitis experimentally produced in rats fed mono-N-methylaniline. J Natl Cancer Inst 1952; 12:777-787.
40. Molland EA. Aspirin damage in the rat kidney in the intact animal and after unilateral nephrectomy. J Pathol 1976; 120:43-48.
41. Johansson S, Angervall L. Urothelial changes of the renal papillae in Sprague-Dawley rats induced by long term feeding of phenacetin. Acta Pathol Microbiol Scand [A] 1976; 84:375-383.
42. Johansson S, Angervall L. Urothelial hyperplasia of the renal papillae in female Sprague-Dawley rats induced by long term feeding of phenacetin. Acta Path Microbiol Scand [A] 1976; 84:353-354.
43. Bokelman DL, Bagdon WJ, Mattis PA, Stonier PF. Straindependent renal toxicity of a nonsteroid anti-inflammatory agent. Toxicol Appl Pharmacol 1971; 19:111-124.
44. Prescott LE. Analgesic nephropathy: A reassessment of the role of phenacetin and other analgesics. Drugs 1982; 23:75-149.
45. Rom W. Tumors of renal pelvis and analgesics. N Engl J Med 1975; 292:47.
46. Hultengren N, Lagergren C, Ljungquist A. Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir Scand 1965; 130:314-320.